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Niemann-PIck Disease Type C: Phenotypic variability often leads to delay In 
diagnosis. C. Prasad\ C. Pushpanathan*, R, Morris3, A. J. Davis* and F. E  
Doughert/ .  Division of Genetics1, Pathology2 and Pediatrics3, Janeway Child Health 
Center, St, John's, Newfoundland, Canada, and the Division of Genetics and 
Metabolism'1 Children's Hospital, Boston, MA.
Niemann-PIck Disease Type C (NP-C) a lipidosis, is caused by a unique 
biochemical defect in cholesterol esteriflcation. The protean manifestations ol this 
condition often cause diagnostic confusion In the early stages. We present 3 cases 
highlighting such phenotypic variations, and distinctive pathological findings of this
disorder.
Case 1: A 2 year and 9 month old boy presented with neonatal hepatitis, 
hapatosplenomegaly and developmental delay. Initial investigations failed to 
establish a cause. A repeat study of the bone marrow showed foamy histiocytes, 
providing a diagnostic clue.
Case 2: A 14 year old boy presented with chronic megaloblastic anemia, 
hepatosplenomegaly and short stature. There were no neurological symptoms. 
Electron microscopic examination of muscle tissue showed complex lipid storage and 
cholesterol crystals in cytosol.
Case 3: A female infant born at 38 weeks gestation developed neonatal 
hepatitis. At 4 months of age she developed respiratory failure requiring aggressive 
ventilation until 2 year and 3 months. She had developmental delay, generalized 
hypotonia and weakness. A muscle, skin and nerve biopsy showed lamellar 
Inclusions suggestive of NP-C.
In each oi the three cases the definitive diagnosis was established by 
demonstration of impaired cholesterol esteriflcation in sTtln libroblasts. In conclusion, 
these cases illustrate the diverse, but common presentations of a rare disorder. 
Pulmonary manifestations (as in case 3) are rarely described In classical NP-C, but 
have been reported in NP-C 2. Unless specifically sought for, a delay In diagnosis Is 
not uncommon, Skin biopsy Is an effective screening tool, while aemonstration of 
defective cholesterol esteriflcation remains the gold standard for diagnosis. With 
limited treatment options, establishing an early diagnosis Is invaluable.
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A CRITICAL EVALUATION OF COPPER METABOLISM IN INDIAN 
WILSON'S CHILDREN WITH SPECIAL REFERENCE TO THEIR 
PHENOTYPES AND RELATIVES, f t  PRASAD, G.KAUR AND B.N.S. WAUA. 
DEPARTMENT OF BIOCHEMISTRY AND PAEDIATRICS* PGIMER, 
CHANDIGARH, INDIA
WILSON'S DISEASE IS AN AUTOSOMAL RECESSIVE DISORDER OF 
COPPER ACCUMULATION LEADING TO LIVER, KIDNEY AND/OR BRAIN 
DAMAGE. SERUM COPPER AND CERULOPLASMIN IN CONTROL 
SUBJECTS (141 CASES OF DIFFERENT TYPES OF LIVER CIRRHOSIS ) 
WERE SIGNIFICANTLY HIGHER AS COMPARED TO WILSON'S DISEASE 
(51) AND THEIR RELATIVES 58) WHILE MARKED HYPERCUPRIURIA 
(145+/-7 ug/24Hrs.)WAS OBSERVED IN WILSON'S CHILDREN ONLY. 
THERE WAS A GOOD CORRELATION (R=0,92) OBSERVED BETWEEN 
COPPER NOT BOUND TO CERULOPLASMIN AND URINARY COPPER 
EXCRETION IN WILSON'S PATIENTS. INTERESTINGLY, 24 HOUR 
URINARY EXCRETION OF COPPER AND C-AMP WERE SIGNIFICANTLY 
(P<0.01) ELEVATED IN WILSON'S CHILDREN ASSOCIATED WITH RENAL 
TABULAR ACIDOSIS AS COMPARED TO PATIENTS WITH 
HEPATOLOGICAL AND/OR NEUROLOGICAL MANIFESTATIONS. 20% 
CASES OF WILSON'S DISEASE AND 25% OF RELATIVES OF WILSON’S 
DISEASE HAD SERUM CERULOPLASMIN BETWEEN 14-20 mg./100ml. 
THEREFORE, 13 CASES OF WILSON'S WERE CONFIRMED BY 
MEASURING HEPATIC COPPER (9CW-8ug/g WET TISSUE: MEAN +/- SD). 
DURING THE FAMILY SCREENING BY SERUM COPPER, 
CERULOPLASMIN AND URINARY COPPER AND HEPATIC COPPER, 10 
SIBLINGS WERE DIAGNOSED TO HAVE PRESYMPTOMATIC WILSON'S 
DISEASE, THESE SUBJECTS WERE THEN STARTED THE D- 
PENICILLAMINE THERAPY, BECAUSE PRESYMPTOMATIC TREATMENT 
PREVENTS PROGRESSION OF THE DISEASE AND ITS COMPLICATIONS,
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Neonatal Hemochromatosis. G. Serra, W. Bonacci, C, Bellini, Servizio di 
Patologia Neonatale, Università' di Genova, Italia.
The female infant was the product of an uneventful 36-week pregnancy. 
Parents were non-consanguineous and healthy. At birth the child was 
jaundiced and had hepatomegaly with ascites. Laboratory studies revealed 
the following: total blirubin 14,5 mg/dl (direct 0,5), albumin 1.7 mg/dl, 
prothrombin time 30", Factor il 16%, V 22%, Vii 16%, X 22%, fibrinogen 
114 mg/dl; ammoniemia was normal. Serum ferritin concentration was 
1,915 mg/ml. Urinary succinylacetone was absent. Alphal-antitrypsin 
deficiency was excluded. All viral and serologic studies and cultures were 
negative. The patient's condition progressively deteriorated and despite
lement the child died on day 21 of life of diffuse uncontrolled 
mucous bleeding. Post mortem evaluaton revealed 
deposits in the liver as well as in other main organs; 
of parenchyma was evident; residual hepatocytes showed 
giant cell transformation was also found. The pathologic 
picture was compatible with the diagnosis of neonatal hemochromatosis 
(NH). NH (OMIM 231100) Is an uncommon polyvisceral iron storage 
disorder of prenatal onset. It is a phenotypically defined disease and it is 
believed that various insults during fatal life may result in the NH phenotype. 
NH Is determined on the basis of a specific pathological diagnosis. Its 
genetic or environmental bases are still unknown. NH is usually considered 
an autosomal recessive disorder. Parents and sibs of patients with NH are 
not necessarily at increased risk of Iron storage disease. NH is not 
genetically related to hereditary hemochromatosis.
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Identification of two novel polymorphisms in the glucocerebrosldase 
gene region. E Sidransky\ E K. Lau\ S. Winfield\ B. K. Stubblefield\ A. 
ZimrarP, N. Tayebi\ and E L Ginns\ 1 Clinical Neuroscience Branch, IRP, 
NIMH, NIHf Bethesda, MD; 2Shaare Zedek Medical Center, Jerusalem,
Israel,
Gaucher disease, an inherited glycolipid storage disorder, is caused by a 
deficiency of the catabolic enzyme glucocerebrosidase. The gene for 
glucocerebrosidase is located on chromosome 1q21 and has a highly 
homplogous pseudogene situated 16kb downstream. We now report two 
novel polymorphisms in the glucocerebrosidase gene region: the first one 
consists of a tetranucleotide (AAAT) repeat upstream to the 
glucocerebrosidase gene, and the second is a series of a dinucleotide (CT) 
repeat In the intergenic region between the glucocerebrosidase gene and its 
pseudogene, These two polymorphisms, along with the previously reported 
Pvu II polymorphism in intron 6 of the glucocerebrosidase gene, were 
analyzed in Gaucher patients (n=106) and two control populations 
(Askenazi n=72 and non-Jewish n=46). Strong linkage disequilibrium was 
found between the common N370S mutation and particular haplotypes, but 
no significant linkage disequilibrium was found in patients carrying the 
L444P or 84GG mutations. We also found exceptions to previous reports 
that the N370S/84GG genotype is always associated with a Pv1,1-/Pv1.1 + 
genotype. Several unusual cases of patients with unexpected haplotypes 
led to the recognition of novel complex alleles, and contribute to our 
understanding of the origin of glucocerebrosidase mutations. The study of 
these markers may reveal possible ancestral chromosomes which led to 
affected alleles, and that may be diagnostically useful in Gaucher patients 
when the specific mutations have not been identified.
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Maternaf hyperhomocystelnemla and occurrence of orofacial clefts In 
offspring, R.P.M.SieegerS'Thounissen^2, W.Y.Wong', A.Kuijpers- 
Jagtnian*, P,HMSpauwon\ B.C.J.HameP, HJ.BIonf, CMG.Thomas7, 
T.K.A.B.EskesK Department of Obstetrics/Gynaecology1, Epidemiology2, 
Orthodontics and Dentistry9, Plastic and Reconstructive Surgery"1, Clinical 
Genetics5, Laboratory of Pediatrics and Neurology0, Laboratory of 
Endocrinology and Reproduction7, University Hospital St Radboud, 
Nijmegen, The Netherlands.(intro.by M.M.Tolarova).
Orofacial cleft (OFC), i.e. cleft lip with or without cleft palate, is a 
classical example of a multifactorial disorder. Evidence has been 
accumulated over the past decade showing that majority of OFC results 
from an interaction between environmental factors, including nutritional 
deficiency or toxicity, and genetic factors. Results from case-control and 
intervention studies suggest that periconceptional vitamin supplementation, 
including folic acid, reduces the recurrence risk of OFC, However, the 
fundamental biological processes that underly the preventive action of folic 
acid supplementation are as yet unknown. Folate and the vitamin 8 ^  and
B6 are involved In the metabolism of homocysteine.
In order to invesigate the folate-dependent homocysteine metabolism, a 
standardized methionine loading test was carried out in 29 mothers of a 
child with OFC and 56 control women.
Surprisingly, in 8 mothers of a OFC child and 2 controls * in the absence 
of liver and kidney dysfunction - hyperhomocysteinemia was established. In 
general, the folate, vitamin and B6 levels were within the normal ranges.
Therefore, this preliminary finding suggests a disorder in the enzymes 
involved in remethylation of homocysteine or in the metabolism of folate and/ 
or vilamin B12.
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Spectrum of Mutations In 21-hydroxylase deficient form of Congenital 
adrenal hyperplasia In Singapore. Agnes Tay1, Kah-Yin LokeLarry  
Poffi. 11nstitute of Molecular and Cell Biology, *Deptof Paediatrics,National 
University of Singapore
Congenital adrenal hyperplasia is due to a deficiency in cytochrome 
P450 enzymes, the most common of which is 21 »hydroxylase. This enzyme 
is encoded by the CYP21 gene on chromosome 6p. Our aim was primarily 
to determine the spectrum of genetic abnormalltes responsible for this 
disease; such analysis has not been previously reported In South-East Asia. 
In addition, we hope to develop rapid screening assays for mutations 
common in our local population.
Fourteen unrelated patients from the Endocrine outpatient clinic were 
studied with a view to characterising the specific mutations. DNA was 
extracted from peripheral leukocytes. The CYP21 gene amplified from 
genomic DNA using the polymerase chain reaction and the products of 
amplification sequenced. Sequencing of six exons and one intron where 
mutations have previously been described revealed mutations in 6 out of 
the 14 individuals. These included: intron 2 splice site mutation (3 patients), 
8-bp deletion in exon 3 (1 patient), I172N missense mutation in exon 4 (1 
patient), and Q318X nonsense mutation in exon 8 (1 patient). For the intron 
2 mutation, allele-specific oligonucleotide hybridization proved to be a 
reliable and rapid screening technique.
Sequencing of the remaining exons is ongoing and we hope to infer 
cjenotype-phenotype correlations when we have catalogued the mutations 
in all tne affected patients.
